Search Results 391-400 of 17430 for Oncogene

  1. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

    ... oncogene receptor tyrosine kinase (ROS1) fusions. Encephalitis, meningitis, or uncontrolled seizures in the year prior to randomization. History of ...

  2. Clinical trials - Oncology (Medical)

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  3. Mayo Study: Genes of Colon Cancer Recurrence Differs Among Blacks, Whites and Asians

    ... oncogenes that provide prognostic information in colon cancer patients,” says Frank Sinicrope, M.D., an oncologist at Mayo Clinic and co-lead author. “Our ...

  4. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation ...

  5. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which ...

  6. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    ... oncogene wild-type left-sided metastatic colorectal cancer (mCRC) having acquired resistance to anti-epidermal growth factor receptor (EGFR) antibody ...

  7. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

    Has confirmation that epidermal growth factor receptor- (EGFR-), anaplastic lymphoma kinase- (ALK-), c-ros oncogene 1- (ROS1-), or B isoform of rapidly ...

  8. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

    ... oncogene homolog (Raf) inhibitors (sorafenib); Note: prior therapy with bevacizumab, sunitinib, pazopanib or aflivercept (vascular endothelial growth factor ...

  9. A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer - Mayo Clinic

    * Additional oncogenic drivers in NSCLC, if known. * Evidence of small cell lung cancer. * Clinical or radiologic evidence of disease recurrence or ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...